Orix IX
NYSE IX
$39.06 +0.04 (+0.10%)
As of: Sep 10, 2026 · 12:57 PM EDT

Orix (IX) EBIT Margin (QoQ) (2009 - 2026)

Analysis

Orix (IX) EBIT Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Orix 43.64 Bn 43.64 Bn 4.68 Bn
2 Royalty Pharma 26.52 Bn 25.68 Bn -
3 Royal Gold 21.74 Bn 21.56 Bn 390.45 Mn
4 OR Royalties 6.80 Bn 6.72 Bn 82.22 Mn
5 Encore Capital 2.10 Bn 1.92 Bn 455.04 Mn
6 Atlanticus Holdings 1.40 Bn 839.95 Mn 686.46 Mn
7 Jefferson Capital 1.18 Bn 1.16 Bn -
8 Upbound 1.07 Bn 961.40 Mn 594.84 Mn
9 Lufax Holding 1.05 Bn -1.58 Bn -
10 Burford Capital 964.43 Mn 964.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 552.00
Mar 31, 2026 -486.00
Dec 31, 2025 -43.00
Sep 30, 2025 -101.00
Jun 30, 2025 1,035.00
Mar 31, 2025 -2,328.00
Dec 31, 2024 2,509.00
Sep 30, 2024 -828.00
Jun 30, 2024 -4,837.00
Mar 31, 2024 4,637.00
Dec 31, 2023 235.00
Sep 30, 2023 -43.00
Jun 30, 2023 -3,583.00
Mar 31, 2023 3,398.00
Dec 31, 2022 463.00
Sep 30, 2022 -326.00
Jun 30, 2022 1,106.00
Mar 31, 2022 -1,000.00
Dec 31, 2021 -522.00
Sep 30, 2021 15.00